New York, NY -- (SBWire) -- 06/21/2019 --This report provides detailed historical analysis of global market for Zirconium Metal from 2014-2018, and provides extensive market forecasts from 2018-2023 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Zirconium Metal market.
Interested in this Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market report? Get your FREE sample now! https://www.marketexpertz.com/sample-enquiry-form/44598
Key players in global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market include:
ACCURAY INC., ACTINIUM PHARMACEUTICALS , INC., ADVANCED ACCELERATOR , APPLICATIONS SA (NOVARTIS , CO.), ADVANCED MEDICAL ISOTOPE , CORP. (NOW VIVOS INC.), ALLIANCE MEDICAL GROUP, AUSTRALIAN NUCLEAR SCIENCE , AND TECHNOLOGY , ORGANISATION, AYTU BIOSCIENCE INC., BAYER PHARMA AG, BLUE EARTH DIAGNOSTICS LTD., BOARD OF RADIATION AND , ISOTOPE TECHNOLOGY, BRACCO DIAGNOSTIC INC., BTG INTERNATIONAL LTD., C. R. BARD INC. (BECTON , DICKINSON), CARDINAL HEALTH INC., CLARITY PHARMACEUTICALS, COQUÍ , RADIOPHARMACEUTICALS , CORP., ECKERT & ZIEGLER BEBIG, ELEKTA, ELI LILLY AND CO., FUJIFILM RI PHARMA CO. LTD., GE HEALTHCARE, IBA MOLECULAR (NOW CURIUM), ISORAY MEDICAL INC., ISO-TEX DIAGNOSTICS INC., JUBILANT DRAXIMAGE INC., LANTHEUS MEDICAL IMAGING , INC., NANOTHEA, NATIONAL CENTRE FOR , NUCLEAR RESEARCH POLATOM, NATIONAL INSTITUTE FOR , RADIOELEMENTS (IRE), NAVIDEA , BIOPHARMACEUTICALS , INC., NORDION INC., NTP RADIOISOTOPES SOC LTD., PHARMALUCENCE INC., PMB ALCEN, SIEMENS HEALTHCARE GMBH , (NOW SIEMENS HEALTHINEERS), SPECTRUM PHARMACEUTICALS , INC., TRIAD ISOTOPES INC., VARIAN MEDICAL SYSTEMS, ZEVACOR MOLECULAR"
Report Scope:
The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2017 to 2023 are provided for each segment and regional market, with estimated values derived from manufacturers' total revenues.
The report also includes a discussion of the major players in each region in the radiopharmaceutical and therapeutics market. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.
Make an Enquiry for a Fast Response of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market Click https://www.marketexpertz.com/make-enquiry-form/44598
Market Segment by Applications, can be divided into
- Aardiology
- Neurology
- Oncology
- Other
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
Summary
Population and human life expectancy are growing globally, spurring more chronic conditions and lifethreatening diseases. Obesity, a sedentary lifestyle and a lack of physical activity have further worsened the situation, leading to the increased importance of medical interventions and treatments. Despite incredible advancements in the field of medicine in the last few decades, an unmet need remains for the prevention, diagnosis and treatment of aggressive ailments such as cancer, cardiovascular diseases and central nervous system disorders.
Since the discovery of radioactivity, it has been recognized that radiation can play a role in the treatment of various diseases. Radiopharmaceuticals are a type of radioactive drug that is internally administered and intended for use in the diagnosis and treatment of diseases. Radiopharmaceuticals are now a crucial part of the healthcare industry, as they can identify various disease processes much earlier than other diagnostic tests. Applications of radiopharmaceuticals are growing significantly in the fields of cardiology, neurology, oncology and other medical specialties such as endocrinology, gastroenterology and nephrology, for both diagnostic and therapeutic purposes.
Growing acceptance and utilization of nuclear medicine scans (i.e., SPECT and PET) and better availability of radiopharmaceuticals due to an increasing number of cyclotrons have significantly contributed to growth in the radiopharmaceutical industry. Innovative technological equipment leading to early and accurate diagnoses, increased awareness of radiopharmaceuticals among physicians and patients and new regulatory approvals of radiopharmaceuticals are other major driving forces for the global radiopharmaceutical market. Furthermore, increasing incidences of different types of cancers across the globe are considered a major driver behind the growth of radiopharmaceuticals and therapeutics. According to Our World in Data, approximately 19 million people had cancer in 1990; that has increased more than two-fold as of 2016, reaching 42 million worldwide. In addition, breast cancer has been identified as the leading type of cancer, as eight million people had breast cancer in 2016. In the same year, 6.3 million, 5.7 million and 2.8 million people had colon and rectum cancer, prostate cancer and tracheal, bronchus and lung cancer, respectively. Hence, the increasing incidences of various cancers drive the need for radiopharmaceuticals and therapeutics, considering diagnostic and therapeutic areas.
#Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market Report to grow your business needs and avail 15% free customization on the report: Now Purchase @ https://www.marketexpertz.com/checkout-form/44598
Report Includes:
- 94 data tables and 83 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Coverage of new products launches and product enhancement in the industry
- Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc."
The report can answer the following questions:
- What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine?
- Who are the global key manufacturers of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
- What are the types and applications of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine? What is the market share of each type and application?
- What are the upstream raw materials and manufacturing equipment of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine? What is the manufacturing process of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine?
- Economic impact on Radiotherapy, Radiopharmaceuticals and Nuclear Medicine industry and development trend of Radiotherapy, Radiopharmaceuticals and Nuclear Medicine industry.
- What will the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market size and the growth rate be in 2023?
- What are the key factors driving the global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine industry?
- What are the key market trends impacting the growth of the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market?
- What are the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market challenges to market growth?
- What are the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market opportunities and threats faced by the vendors in the global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine market?
Browse Full RD with TOC of This Report @ https://www.marketexpertz.com/industry-overview/radiotherapy,-radiopharmaceuticals-and-nuclear-medicine-market
About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.
Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Market by Forecast to 2023 Key Manufacture –Bayer Pharma AG, Eli Lilly and Company, Siemens Healthcare
This report provides detailed historical analysis of global market for Radiotherapy, Radiopharmaceuticals and Nuclear Medicine from 2014-2018, and provides extensive market forecasts from 2018-2023 by region/country and subsectors.